ZYBERNO
Stock Report
Updated Sep 1, 2026

Achieve Life Sciences, Inc. (ACHV)

Healthcare • NASDAQ

$8.10

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
0.0/100
POOR BUSINESS
Achieve Life Sciences, Inc. (ACHV) scores 0/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-892.1%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-303.1%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

Achieve Life Sciences, Inc. (ACHV) stock report — Zyberno Score 0/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:8.10
Market Cap:$757.44M

Valuation Multiples (1)

Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$570.18M

Price Action & Momentum (3)

Momentum Percentile:97 / 100
% of 52-Week High:94.1%
B. Profitability Assessment

Return Metrics (5)

ROA:-143.7%
Reinvestment Rate:2.4%
Fundamental Growth Rate (g):-7.2%

Margin Analysis (1)

Ebitda Margin:0.0%

Yield Metrics (2)

Earnings Yield:-$18.52
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-346.0%
Latest Earnings Filed:2026-08-11
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.95x
Quick Ratio:0.95x
Cash Ratio:0.95x

Leverage Analysis (1)

Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-54.98x
Times Interest Earned:-54.98

Capital Structure (4)

Working Capital:-9,363,000.00
Cash And Cash Equivalents:187,300,000.00
Long Term Debt:$5.00K
Net Debt:-$187.26M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$0.00
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$0.00-$12.69M

Bottom Line Performance (3)

-$114.04M
Income Before Tax:-$12.69M
Ebitda Ttm:-12,464,000.00

Operating Expenses (5)

Operating Expenses:58,278,000.00
R And D Expense:26,420,000.00
Sga Expense:25,919,000.00
Income Tax Expense:$0.00
Interest Expense:994,000.00

Expense Ratios (1)

Ebitda Margin:0.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$190.44M
Current Assets:$188.29M
Ppe Net:15,000.00
Goodwill:1,034,000.00
Intangible Assets:$640.00K

Liability Structure (4)

Total Liabilities:205,115,000.00
Current Liabilities:197,657,000.00
Long Term Debt:$5.00K
Short Term Debt:$36.00K

Equity & Capital (3)

Equity:-$14.68M
Retained Earnings:-$345.16M
Common Stock:150,000,000.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:0.00
Accounts Payable:200,000.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:6,955,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$45.31M-$45.33M

Investment Activities (2)

Investing Cash Flow:$14.28M
Capital Expenditures Ttm:17,000.00

Financing Activities (3)

Financing Cash Flow:$21.00K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:223,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-1.50
-$1.50
Earnings Per Share Ttm:-$1.22

Revenue & Cash Per Share (1)

Operating Cash Flow Per Share:-$0.53

Book Value & Capital (2)

Book Value Per Share:-$0.16
Cash Per Share:2.00

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (1)

Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:-999.00
Cash Conversion Cycle:-999.00
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:20.00
Quality Score:10.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:2.4%
Fundamental Growth Rate (g):-7.2%
B. Log-Linear Regression Growth Analysis

Other Growth Rates (1)

Book Value Growth Rate (Linear):60.6%
C. Company Profile & Context

Corporate Information (6)

Symbol:ACHV
Company Name:Achieve Life Sciences, Inc.
Sector:Healthcare
Industry:Medical Diagnostics
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:93.51M
Shares Outstanding Basic:93.51M
Shares Outstanding Diluted:93.51M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 19:50:06 UTC
Data Timestamp:2026-09-01T19:50:06.124529
Scroll to Top